ST. LOUIS, MO - RiverVest Venture Partners announced today that it has completed fundraising for its second fund, RiverVest Venture Fund II, L.P., with total committed capital of $75 million from private investors. RiverVest’s first fund, which was licensed as a Small Business Investment Company, had total private capital of $45 million,plus one tier of leverage from the Small Business Administration.

Read More…

ST. LOUIS, MO and CLEVELAND, OH - RiverVest Venture Partners, a life science venture capital firm headquartered in St. Louis, MO, announced today that it will be opening an office at the BioEnterprise facility in Cleveland, OH. The office will be managed by Karen Spilizewski, who is joining RiverVest on a part-time basis as a vice president on January 1, 2008. RiverVest co-founder and managing director, Jay Schmelter, said, “We are excited about the investment prospects in Ohio, which led all Midwestern states in life science venture capital investments through the first nine months of 2007.

Read More…

ST. LOUIS, MO – RiverVest Venture Partners®, a venture capital firm investing nationwide in emerging medical technology and biopharmaceutical companies, today announced that Gordon Foulkes, Ph.D., has joined the firm as a Venture Partner. Dr. Foulkes brings to RiverVest extensive operational experience in biopharmaceutical research and development. Prior to joining RiverVest, he headed research and development in three biotechnology companies where he helped raise $145 million in private and public offerings and secure more than $200 million in 15 corporate partnerships. 

Read More…

ST. LOUIS, MO - RiverVest Venture Partners®, a venture capital firm investing nationwide in emerging medical technology and biopharmaceutical companies, has named Dennis Wahr, M.D., to the position of managing director. Wahr, a specialist in cardiac medicine, brings to the firm more than 25 years of experience in clinical practice and medical device entrepreneurship. He is a former practicing interventional cardiologist and founder of Velocimed, LLC, where he served as president and CEO until the recent acquisition of the company’s business by St. Jude Medical. 

Read More…

ST. LOUIS, MO - RiverVest Venture Partners, a national venture capital firm focusing on seed and early-stage life sciences investments, has named Scott R. Naisbitt, M.D., Ph.D. an associate and Floyd E. Bloom, M.D., a scientific advisor.

Read More…